Hong Kong, 25 September 2026—China Risun Group Limited (China Risun) disclosed to the Hong Kong Stock Exchange that it repurchased 1.00 million ordinary shares on 25 September 2026. The on-market transaction was executed within a price range of HKD 1.55–1.615 per share, at a volume-weighted average cost of HKD 1.589 per share, for a total consideration of HKD 1.59 million.

Prior to the trade, China Risun had 4.250 billion issued shares excluding treasury stock. Post-repurchase, the outstanding share count declined to 4.249 billion—an incremental reduction of 0.02%. Treasury shares rose to 205.01 million, while the company’s total issued share capital (treasury plus non-treasury) remained at 4.454 billion.

The buy-back forms part of the general mandate approved at the 29 May 2026 annual general meeting, authorising the board to repurchase up to 427.86 million shares (10% of the company’s issued share capital at that date). Including the latest transaction, China Risun has repurchased 29.44 million shares under this mandate, equivalent to 6.88% of the authorised limit and 0.69% of the company’s share base as of the mandate date.

In accordance with Hong Kong listing rules, a 30-day moratorium on new share issues or further sales of treasury shares is in place until 25 October 2026. The company confirmed that all repurchase activities complied with the Main Board Listing Rules and the terms of the approved mandate.